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IPD cases in adults ≥18 years; PCV13 serotypes accounted for 53% in 2009 and 25% 
of IPD in 2016. The correlations between IPD (ABC) with INV pneumonia (SENTRY) 
and N-INV pneumonia (SENTRY) were: 0.937 and 0.973 (both P < 0.01), respectively 
(Table  1). The proportion of IPD and N-INV pneumonia due to vaccine serotypes 
decreased consistently and monotonically until 2014 and then plateaued (Figure 1).
Conclusion. We found a strong correlation between databases (SENTRY and 
ABC) and between INV and N-INV pneumococcal disease in the proportion of dis-
ease due to PCV13 types. Our findings would need to be confirmed at the individual 
serotype level. The observed decrease in PCV13-type disease through 2014 is compat-
ible with herd effect from PCV13 vaccination in children. The plateau suggests remain-
ing disease that may be addressed by direct vaccination of adults. Surveillance of IPD 
alone could guide some policy on PCV13-type pneumococcal pneumonia.
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Background. S. pneumoniae (SP) is one of the most important bacteria for pneu-
monia among adults. We investigated hospital-based proportion of antimicrobial 
resistance, distribution of serotypes, sequence types (STs) and clinical findings among 
adult pneumococcal pneumonia patients, and compared microbiological results with 
the previous study that was reported 10 years ago in Japan.
Methods. A multicenter prospective surveillance for adult pneumonia was con-
ducted from September 2011 to August 2014 in Japan. We enrolled aged over 15 years, 
community-acquired or healthcare-associated pneumonia patients, and obtained clin-
ical information and sputum samples. Sputum samples were cultured quantitatively or 
qualitatively at each study sites. Identified SP strains were transported to our laboratory 
for serotyping by the Quellung reaction. We also extracted DNA from SP strains for 
multilocus sequence typing. Antimicrobial sensitivity tests for penicillin (PCG), ceftri-
axone (CTRX), and meropenem (MEPM) were conducted using agar dilution method. 
Differences of clinical findings were analyzed using the chi-square test.
Results. We enrolled 200 cases and obtained 205 SP strains. Most domin-
ant serotype was three (24.4%) and ST was 180 (22.9%). Those results were same as 
the previous report. The proportion of 13-valent pneumococcal conjugate vaccine 
and 23-valent pneumococcal polysaccharide vaccine serotypes was 58.5 and 75.6%, 
respectively. Most of SP strains were sensitive for antibiotics (96.1% for PCG, 94.1% 
for CTRX, and 81.5% for MEPM) and the antimicrobial sensitivity also did not greatly 
have a change with the previous study reported 10 years ago. Pneumococcal pneumo-
nia patients due to serotype 3 was higher hospitalization rate and CURB-65 score than 
other serotypes (hospitalization rate was 73.5 and 60.3%, respectively; P = 0.095, and 
proportion of 3 or more CURB-65 score was 36.4 and 20.7%, respectively; P = 0.039).
Conclusion. In Japan, SP sensitivity for antibiotics, dominant serotype and ST 
were not changed so much from 10 years ago. Serotype 3 SP contributed to the disease 
severity of adult pneumococcal pneumonia in Japan.
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Background. According to the National Alliance on Mental Illness, one in five 
American adults experiences a mental health condition every year. CAP is often 
treated with antibiotics that can prolong the QTc interval. The primary outcome was 
to assess whether those with a psychiatric disorder were more likely to experience 
treatment failure and have poor outcomes in the treatment of community acquired 
pneumonia (CAP).
Methods. A retrospective chart review was performed using ICD-9/10 codes for 
CAP between January 1, 2008 and January 31, 2018. Patients were included if they 
were seen at the Western New York VA Healthcare System, emergency room, primary 
or rural care clinics. Data were analyzed via the Student’s t-test or chi-squared test.
Results. A total of 518 patients met criteria and 49% had a psychiatric disorder. 
Compared with patients without psychiatric disorders, patients with psychiatric 
co-morbidity were more likely to receive an appropriate dose of antibiotics (99.4% vs. 
93.6% P = 0.0004) as well as an appropriate duration (78% vs. 68% P = 0.03). Patients 
with a psychiatric disorder were not more likely to experience failure or subsequent 
admission. There was no statically significant difference in early or late CAP treatment 
failure in those with a psychiatric disorder compared with those without (P = 0.3383; 
P = 0.116). There was also no statistically significant difference in 30-day readmission 
rates, 30-day mortality, or 90-day mortality (P = 0.4095; P = 0.3383; P = 0.3790). They 
were more likely to be prescribed conditional risk QTc prolonging agents concomi-
tantly (70.2% vs. 26.9% P < 0.0001); however, differences in prescribing rates of a QTc 
prolonging antibiotic, such as a fluoroquinolone or macrolide, were not statistically 
significant (85.3% vs. 83.4% P = 0.5353).
Conclusion. While mental illness is often associated with poor outcomes, this 
study emphasizes the need to continue to remove the stigma of mental illness when 
treating patients with common outpatient infections.
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Background. The Infectious Diseases Society of America (IDSA) made guide-
lines for management of community acquired pneumonia (CAP) in healthy infants 
and children older than 3 months of age. These were made to assist clinicians in choos-
ing appropriate antimicrobial therapy in order to decrease morbidity and mortality 
and minimize antimicrobial resistance. Accordingly, narrow-spectrum antibiotics as 
first-line treatment but inappropriate selection of broad-spectrum antibiotics remains 
high. Our study investigates the concordance between emergency department (ED) 
and in-patient prescribers in choosing appropriate antibiotic therapy for CAP.
Methods. This retrospective chart reviews the aforementioned population who 
were admitted to the inpatient pediatric service via the ED from January 1, 2015–
December 1, 2017. Data collection included patient demographics, prior antibiotic 
use from an outside prescriber, the antimicrobial prescribed in the ED, and the anti-
microbial used in the pediatric unit. The primary outcome determined the consistency 
between the prescribing pattern in the ED and the inpatient. A descriptive statistical 
analysis was conducted afterward.
Results. A total of 210 patients were admitted to the inpatient pediatric service. 
The ED prescribed an aminopenicillin to 2.9% of patients or a cephalosporin as mon-
otherapy to 70.9%; 0.9% of patients were started on both types. Once under the hos-
pitalist’s service, the hospitalist continued the cephalosporin in 72.4%, switched to an 
aminopenicillin in 10.6%, switched to a macrolide in 5.4%, and 8.1% discontinued 
antimicrobrials altogether. If an aminopenicillin was started in the ED, it was contin-
ued by the hospitalist in 83.3% of the cases, with none switching to a cephalosporin, 
and one patient being switched to a macrolide.
Conclusion. At our local pediatric hospital, there is poor compliance with IDSA 
guidelines for CAP. There is high concordance between ED and in-patient prescribers 
since hospitalists were more likely to continue the antimicrobial started in the ED. 
Guideline adherence might be improved by focus on antibiotic stewardship and creat-
ing order sets that adhere to IDSA guidelines. Future studies could investigate if these 
suggestions improve overall adherence rates.
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Background. Previous studies reported that Moraxella catarrhalis was one of the 
main pathogen in community-acquired pneumonia (CAP); however, only a few inves-
tigations describing CAP due to M. catarrhalis (MCAP) have been published until now. 
Therefore, the data regarding clinical features of MCAP is still unknown.
Methods. The primary objective of the present study was to determine the clinical 
characteristics of patients with MCAP. Pneumonia patients aged over 20 hospitalized 
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